Clal Insurance’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $138M | Hold |
2,175,282
| – | – | 0.62% | 41 |
|
|
2026
Q1 | $165M | Sell |
2,175,282
-210,000
| -9% | -$15M | 0.99% | 23 |
|
|
2025
Q4 | $148M | Sell |
2,385,282
-600,000
| -20% | -$35.3M | 0.96% | 25 |
|
|
2025
Q3 | $177M | Sell |
2,985,282
-100,000
| -3% | -$5.83M | 1.35% | 19 |
|
|
2025
Q2 | $181M | Buy |
3,085,282
+400,000
| +15% | +$22.6M | 1.78% | 16 |
|
|
2025
Q1 | $135M | Buy |
2,685,282
+190,000
| +8% | +$9.72M | 1.39% | 17 |
|
|
2024
Q4 | $113M | Hold |
2,495,282
| – | – | 1.01% | 27 |
|
|
2024
Q3 | $121M | Buy |
2,495,282
+1,100,000
| +79% | +$53M | 1.07% | 27 |
|
|
2024
Q2 | $71.8M | Buy |
1,395,282
+510,000
| +58% | +$27.9M | 0.75% | 31 |
|
|
2024
Q1 | $48.6M | Buy |
885,282
+534,000
| +152% | +$27.8M | 0.55% | 47 |
|
|
2023
Q4 | $20M | Sell |
351,282
-1,010,000
| -74% | -$57.1M | 0.26% | 65 |
|
|
2023
Q3 | $84.8M | Buy |
1,361,282
+1,150,000
| +544% | +$72.8M | 1.18% | 19 |
|
|
2023
Q2 | $12.6M | Sell |
211,282
-2,311,871
| -92% | -$147M | 0.15% | 79 |
|
|
2023
Q1 | $188M | Sell |
2,523,153
-1,070,000
| -30% | -$82.6M | 2.81% | 10 |
|
|
2022
Q4 | $264M | Sell |
3,593,153
-361,039
| -9% | -$28.5M | 3.96% | 3 |
|
|
2022
Q3 | $332M | Sell |
3,954,192
-74,646
| -2% | -$6.42M | 4.55% | 3 |
|
|
2022
Q2 | $323M | Sell |
4,028,838
-1,990,317
| -33% | -$193M | 4.3% | 3 |
|
|
2022
Q1 | $629M | Buy |
6,019,155
+1,456,027
| +32% | +$121M | 6.63% | 2 |
|
|
2021
Q4 | $343M | Buy |
4,563,128
+1,741,558
| +62% | +$122M | 3.71% | 3 |
|
|
2021
Q3 | $183M | Buy |
2,821,570
+45,500
| +2% | +$2.78M | 2.09% | 12 |
|
|
2021
Q2 | $168M | Buy |
2,776,070
+272,567
| +11% | +$16.1M | 1.92% | 11 |
|
|
2021
Q1 | $135M | Buy |
2,503,503
+940,000
| +60% | +$51.1M | 1.56% | 18 |
|
|
2020
Q4 | $70.4M | Buy |
1,563,503
+600,000
| +62% | +$26.5M | 0.96% | 38 |
|
|
2020
Q3 | $37.8M | Buy |
963,503
+659,826
| +217% | +$24M | 0.64% | 53 |
|
|
2020
Q2 | $9.75M | Buy |
303,677
+59,995
| +25% | +$2.09M | 0.19% | 84 |
|
|
2020
Q1 | $8.27M | Buy |
243,682
+224,342
| +1,160% | +$8.98M | 0.21% | 77 |
|
|
2019
Q4 | $404K | Sell |
19,340
-984,342
| -98% | -$47.6M | 0.43% | 54 |
|
|
2019
Q3 | $50.1M | Buy |
1,003,682
+158,895
| +19% | +$8.11M | 1.22% | 27 |
|
|
2019
Q2 | $45.2M | Sell |
844,787
-1,596
| -0.2% | -$83.3K | 1.04% | 36 |
|
|
2019
Q1 | $44.9M | Buy |
846,383
+346,383
| +69% | +$18M | 1.1% | 34 |
|
|
2018
Q4 | $23.5M | Buy |
+500,000
| New | +$26.1M | 0.61% | 41 |
|
Other funds holding NTR
Clal Insurance's NTR Position: Q2 2026 in Review
Clal Insurance held its Nutrien (NTR) position steady in Q2 2026 at 2,175,282 shares worth $138M. The position accounts for 0.62% of the portfolio, ranked #41.
Clal Insurance first reported a position in NTR in Q4 2018 and has held it in 31 quarters since. The position peaked at $629M in Q1 2022. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.
- Clal Insurance held 2,175,282 shares of Nutrien worth $138M as of Q2 2026.
- Clal Insurance left its Nutrien share count unchanged in Q2 2026.
- Nutrien made up 0.62% of Clal Insurance's portfolio in Q2 2026, its #41 holding.
- Clal Insurance first reported a position in Nutrien in Q4 2018 and has held it in 31 quarters since.
- Clal Insurance's Nutrien position peaked at $629M in Q1 2022.
- 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.
Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.